PROCEPT BioRobotics (PRCT) Revenue (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Revenue for 7 consecutive years, with $94.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 19.34% year-over-year to $94.5 million in Q2 2026; TTM through Jun 2026 was $337.3 million, a 22.69% increase from a year earlier, with the FY2025 full-year figure at $308.1 million, up 37.22% from the prior year.
• Revenue was $94.5 million for Q2 2026 at PROCEPT BioRobotics, up from $83.1 million in the prior quarter.
• Over five years, Revenue peaked at $94.5 million in Q2 2026 and troughed at $14.2 million in Q1 2022.
• A 5-year average of $51.2 million and a median of $48.9 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 134.76% in 2022 and increased 11.94% in 2025, its largest moves.
• Over 5 years, Revenue stood at $23.8 million in 2022, then jumped by 83.29% to $43.6 million in 2023, then soared by 56.57% to $68.2 million in 2024, then advanced by 11.94% to $76.4 million in 2025, then climbed by 23.72% to $94.5 million in 2026.
• The last three Revenue figures came in at $94.5 million (Q2 2026), $83.1 million (Q1 2026), and $76.4 million (Q4 2025), per Business Quant data.